当前位置:首页 - 行情中心 - 山河药辅(300452) - 财务分析 - 资产负债表

山河药辅

(300452)

  

流通市值:23.41亿  总市值:29.38亿
流通股本:1.87亿   总股本:2.34亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金116,515,129.94431,955,369.86143,408,166.98150,119,055.59
应收票据及应收账款142,945,151.84120,277,614.08147,473,524.6598,185,857.68
其中:应收票据37,431,868.5144,695,634.8848,694,876.0846,182,376.03
应收账款105,513,283.3375,581,979.298,778,648.5752,003,481.65
应收款项融资32,369,114.0337,104,839.0528,042,559.4925,204,299.83
预付款项18,702,881.5614,226,348.7119,306,395.7228,466,594.28
其他应收款合计300,935.56321,932.42463,917.3592,000.25
存货73,642,045.6682,184,687.0783,423,079.6291,197,744.75
其他流动资产-26,886.7310,108,032.7822,990,211.89
流动资产平衡项目0000
流动资产合计880,185,319.57889,940,759.84639,739,569.7631,320,405.29
非流动资产:
固定资产270,279,228.13278,005,686.53283,956,591.15285,237,178.7
在建工程222,607,742.85202,965,908.62157,958,503.62154,591,705.58
无形资产52,692,355.2153,015,992.8153,339,630.4153,663,268.01
商誉39,126,854.8439,126,854.8439,126,854.8439,126,854.84
长期待摊费用1,697,598.14865,757.34921,527.16977,296.98
递延所得税资产11,528,205.2510,989,286.7510,923,870.1812,659,978.22
其他非流动资产4,306,214.356,852,953.3520,756,043.162,974,274.49
非流动资产平衡项目0000
非流动资产合计602,238,198.77591,822,440.24566,983,020.52549,230,556.82
资产平衡项目0000
资产总计1,482,423,518.341,481,763,200.081,206,722,590.221,180,550,962.11
流动负债:
短期借款18,000,00029,066,818.340,009,763.9139,842,812.98
应付票据及应付账款192,654,722.87209,940,503.25212,540,352.7225,946,483.11
其中:应付票据111,400,891.4117,590,732.7137,480,764.8120,251,030.9
应付账款81,253,831.4792,349,770.5575,059,587.9105,695,452.21
预收款项55,25580,770105,050126,470
合同负债4,777,787.585,245,462.3411,002,160.5322,453,755.58
应付职工薪酬7,357,896.37,480,855.427,244,472.2913,022,833.07
应交税费8,048,622.746,165,086.581,823,313.611,848,896.11
其他应付款合计7,039,682.117,790,236.46,943,402.117,636,186.21
其中:应付利息192,876.7131,561.64--
其他流动负债15,624,216.3425,082,747.8533,862,287.4434,372,987.67
流动负债平衡项目0000
流动负债合计253,558,182.94290,852,480.14313,530,802.59345,250,424.73
非流动负债:
应付债券275,983,509.66272,762,911.96--
递延收益35,849,762.8636,641,591.8537,159,420.8431,125,027.32
递延所得税负债16,748,434.7616,119,981.5615,900,914.9915,557,794
非流动负债平衡项目0000
非流动负债合计328,581,707.28325,524,485.3753,060,335.8346,682,821.32
负债平衡项目0000
负债合计582,139,890.22616,376,965.51366,591,138.42391,933,246.05
所有者权益(或股东权益):
实收资本(或股本)234,460,291234,460,291234,460,291234,522,691
其他权益工具43,931,246.1543,931,246.15--
资本公积65,510,613.3865,436,020.9965,361,428.665,810,996.21
减:库存股5,244,848.15,244,848.15,244,848.15,831,408.1
专项储备515,165.77495,424.82491,625.7574,841.32
盈余公积73,444,882.9273,444,882.9273,444,882.9273,444,882.92
未分配利润419,415,901.26384,214,065.97403,888,167.86354,499,882.51
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计832,033,252.38796,737,083.75772,401,548.03722,521,885.86
少数股东权益68,250,375.7468,649,150.8267,729,903.7766,095,830.2
股东权益平衡项目0000
股东权益合计900,283,628.12865,386,234.57840,131,451.8788,617,716.06
负债和股东权益合计1,482,423,518.341,481,763,200.081,206,722,590.221,180,550,962.11
公告日期2023-10-252023-08-242023-04-212023-04-08
审计意见(境内)标准无保留意见
TOP↑